Observational study in an outpatient clinic specializing in treating opioiddependent pregnant women: Neonatal abstinence syndrome in infants exposed to methadone-, buprenorphine- and slow-release oral morphine

Heroin Addiction and Related Clinical Problems

Volumn 17, Issue 1, 2015, Pages 5-16

  Metz, Verena E ^a,b   Comer, Sandra D ^a   Pribasnig, Anna ^b   Wuerzl, Johanna ^b   Fischer, Gabriele ^b,c  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Medical University of Vienna and Wiener Werkstaette for Suicide Research   (Austria)

Author keywords

Breastfeeding; Neonatal outcome; Opioid dependence; Opioid maintenance therapy; Pregnancy

Indexed keywords

BUPRENORPHINE; METHADONE; MORPHINE; NICOTINE;

ADULT; ARTICLE; BREAST FEEDING; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; GESTATIONAL AGE; HUMAN; OBSERVATIONAL STUDY; OPIATE ADDICTION; OUTPATIENT DEPARTMENT; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PUERPERIUM; SLOW RELEASE FORMULATION; THIRD TRIMESTER PREGNANCY; WITHDRAWAL SYNDROME;

EID: 84931378891     PISSN: 15921638     EISSN: 25314122     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drugdependent mothers. Pediatrics 2006;117(6):e1163-9.
2. American Academy of Pediatrics Committee on Drugs. Neonatal drug withdrawal. Pediatrics 1998;101(6):1079- 1088.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC, 2000.
4. Baewert A, Jagsch R, Winklbaur B, Kaiser G, Thau K, Unger A, Aschauer C, Weninger M, Metz V. Influence of site differences between urban and rural American and Central European opioid-dependent pregnant women and neonatal outcome characteristics. Eur Addict Res 2012;18(3):130-9.
5. Bakstad B, Sarfi M, Welle-Strand GK, Ravndal E. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study. Eur Addict Res 2009;15(3):128-34.
6. Beck T, Haasen C, Verthein U, Walcher S, Schuler C, Backmund M, Ruckes C, Reimer J. Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone. Addiction 2014;109(4):617-26.
7. Choo RE, Huestis MA, Schroeder JR, Shin AS, Jones HE. Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend 2004;75(3):253-60.
8. Cleary BJ, Donnelly J, Strawbridge J, Gallagher PJ, Fahey T, Clarke M, Murphy DJ. Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis. Addiction 2010;105(12):2071-84.
9. Dryden C, Young D, Hepburn M, Mactier H. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG 2009;116(5):665-71.
10. Ebner N, Rohrmeister K, Winklbaur B, Baewert A, Jagsch R, Peternell A, Thau K, Fischer G. Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend 2007;87(2-3):131-8.
11. European Monitoring Centre for Drugs and Drug Addiction. Annual report 2012: the state of the drugs problem in Europe. Luxembourg: Publications Office of the European Union - [cited 2014 Sept 1]. Available from:http://www.emcdda.europa.eu/publications/ annual-report/2012
12. Fagerström KO, Schneider NG. Measuring nicotine dependence: A review of the Fagerström Tolerance Questionnaire. J Behav Med 1989;12:159-181.
13. Finnegan LP. Women, pregnancy and methadone: Heroin Add & Rel Clin Probl 2000; 2(1):1-8.
14. Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis 1975;2(1-2):141-58.
15. Fischer G, Jagsch R, Eder H, Gombas W, Etzersdorfer P, Schmidl-Mohl K, Schatten C, Weninger M, Aschauer HN. Comparison of methadone and slow-release morphine maintenance in pregnant addicts. Addiction 1999;94(2):231-9.
16. Fischer G, Ortner R, Rohrmeister K, Jagsch R, Baewert A, Langer M, Aschauer H. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction 2006;101(2):275-81.
17. Gsellhofer B, Fahrner R EM, Platt J. European Addiction Severity Index EuropASI (German version). Munich, Germany: IFT Institute for Therapy Research, 1994.
18. Gsellhofer B, Küfner H, Vogt M, Weiler D. European Addiction Severity Index. EuropASI. Manual für Training und Durchführung. Baltmannsweiler, Schneider-Verlag Hohengehren GmbH; 1999. German.
19. Grim K, Harrison TE, Wilder RT. Management of neonatal abstinence syndrome from opioids. Clin Perinatol 2013;40(3):509-24.
20. Hodgson ZG, Abrahams RR. A rooming-in program to mitigate the need to treat for opiate withdrawal in the newborn. J Obstet Gynaecol Can 2012;34(5):475-81.
21. Huestis MA, Choo RE. Drug abuse's smallest victims: in utero drug exposure. Forensic Sci Int 2002;128(1- 2):20-30. Review.
22. Isemann B, Meinzen-Derr J, Akinbi H. Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome. J Perinatol 2011;31(1):25-9.
23. Jansson LM, Velez M. Neonatal abstinence syndrome. Curr Opin Pediatr 2012;24(2):252-8.
24. Jones HE, Jansson LM, O'Grady KE, Kaltenbach K. The relationship between maternal methadone dose at delivery and neonatal outcome: Methodological and design considerations. Neurotoxicol Teratol 2013;39:110-5.
25. Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR, Fischer G. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010;363(24):2320-31.
26. Kaltenbach K, Holbrook AM, Coyle MG, Heil SH, Salisbury AL, Stine SM, Martin PR, Jones HE. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. Addiction 2012;107 Suppl 1:45-52.
27. Lejeune C, Genest L, Miossec E, Simonpoli AM, Simmat- Durand L. [Retrospective analysis of neonatal data in a monocentric cohort of 170 newborns of polydrugusing mothers, Île-de-France, 1999-2008]. Arch Pediatr 2013;20(2):146-55.
28. Logan BA, Brown MS, Hayes MJ. Neonatal abstinence syndrome: treatment and pediatric outcomes. Clin Obstet Gynecol 2013;56(1):186-92.
29. Metz VE, Brandt L, Unger A, Fischer G. Substance abuse/dependence treatment: A European perspective. Subst Abus 2014;35(3):309-20.
30. O'Connor AB, Collett A, Alto WA, O'Brien LM. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. J Midwifery Womens Health 2013;58(4):383-8.
31. Osborn DA, Jeffery HE, Cole MJ. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev 2010;(10):CD002059.
32. Priebe S, Gruyters T, Heinze M, Hoffmann C, Jäkel A. Subjective evaluation criteria in psychiatric care-- methods of assessment for research and general practice. Psychiatr Prax 1995;22(4):140-4. German.
33. Pritham UA. Breastfeeding promotion for management of neonatal abstinence syndrome. J Obstet Gynecol Neonatal Nurs 2013;42(5):517-26.
34. Pritham UA, Paul JA, Hayes MJ. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. J Obstet Gynecol Neonatal Nurs 2012;41(2):180-90.
35. Seligman NS, Salva N, Hayes EJ, Dysart KC, Pequignot EC, Baxter JK. Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates. Am J Obstet Gynecol 2008;199(4):396.e1-7.
36. Thajam D, Atkinson DE, Sibley CP, Lavender T. Is neonatal abstinence syndrome related to the amount of opiate used? J Obstet Gynecol Neonatal Nurs 2010;39(5):503-9.
37. Velez M, Jansson LM. The opioid dependent mother and newborn dyad: non-pharmacologic care. J Addict Med 2008; 2(3): 113-20.
38. Wachman EM, Byun J, Philipp BL. Breastfeeding rates among mothers of infants with neonatal abstinence syndrome. Breastfeed Med 2010;5(4):159-64.
39. Welle-Strand GK, Skurtveit S, Jansson LM, Bakstad B, Bjarkø L, Ravndal E. Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta Paediatr 2013;102(11):1060-6.
40. Winklbaur B, Baewert A, Jagsch R, Rohrmeister K, Metz V, Aeschbach Jachmann C, Thau K, Fischer G. Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatment. Eur Addict Res 2009;15(3):150-6.